Overview Service Features FAQs Scientific Resources Related Services
With many years of experience and powerful technologies, Creative Biolabs has developed an innovative STEMOD™ platform to provide drug discovery services for our customers all over the world. Our dedicated team of specialists has an in-depth understanding of stem cell-based drug discovery and development, and will help you find the best-fit solution for your research requirements. In addition, we have optimized systems to quickly get satisfactory results and contribute greatly to the success of your programs. Whether you are conducting drug discovery or complex biological research, rely on our experienced staff to design and conduct your studies using cutting-edge technology in our state-of-the-art facilities.
Overview of STEMOD™ based Drug Discovery
Our STEMOD™ based drug discovery service is an innovative platform designed to accelerate the identification and development of novel therapeutics. It employs advanced biotechnological methodologies and proprietary technologies to enhance drug discovery processes, with a focus on stem cell technologies, high-throughput screening, and in vitro models.
STEMOD™ based Drug Discovery Service
STEMOD™ based drug discovery service represents a frontier in biotechnology, merging cutting-edge science with practical applications for drug development. With its emphasis on stem cell technology and advanced screening methodologies, it aims to revolutionize how therapeutics are discovered and developed, ultimately enhancing the efficiency of bringing new drugs to market.
To learn how our STEMOD™ based services advance your research in a selection of areas, please do not hesitate to contact us .
Our services can be applied in the following research areas.
-
Oncology: Discovery of targeted therapies by utilizing patient-derived stem cells to evaluate responses against a range of anticancer agents.
-
Neurodegenerative Diseases: Developing compounds for diseases like Alzheimer's and Parkinson's by utilizing functional assays on neuronal cells derived from stem cells.
-
Cardiovascular Research: Screening for cardioprotective agents using heart cells derived from iPSCs.
Service Features
Key features of our service:
-
Stem Cell Technology Integration
-
Customized Drug Discovery Solutions - Offers tailored solutions based on client requirements, including target identification, lead optimization, and preclinical development support.
-
Data Management and Analysis - Employs cloud-based data management systems for seamless integration and analysis of experimental results.
-
Regulatory Support - Guides clients through the regulatory landscape, offering assistance in compliance with FDA and EMA regulations for drug development.
FAQs
-
Q: Can the STEMOD™ platform be integrated with high-throughput screening for large compound libraries?
A: Yes, the STEMOD™ platform is compatible with HTS. We can scale up the organoid production to screen large libraries of compounds efficiently. This allows for rapid identification of potential drug candidates while maintaining the accuracy and physiological relevance of the 3D models, providing you with robust data for further development.
-
Q: What support is provided during the process, and how involved can I be in the experimental design?
A: We provide extensive support throughout the entire process, from initial consultation to data analysis. Our team of experts will work closely with you to design experiments that meet your research objectives. You can be as involved as you like in the experimental design, and we offer regular updates and consultations to ensure the project aligns with your expectations.
-
Q: How long does it typically take to receive results when using the STEMOD™ service for drug screening?
A: The timeline for results can vary based on the complexity of the organoids used and the scope of the screening process. However, our standard drug screening assays using STEMOD™ typically take 4 to 8 weeks. We prioritize timely delivery of results while maintaining high-quality data, and we will keep you updated throughout the process to ensure your project stays on track.
-
Q: Can the STEMOD™ platform be integrated with other technologies like CRISPR or omics approaches to enhance drug discovery?
A: Absolutely, the STEMOD™ platform is highly compatible with other cutting-edge technologies. For example, we can use CRISPR/Cas9 to introduce specific genetic mutations into stem cells, allowing us to model genetic diseases or test gene-editing therapies. Additionally, we can integrate various omics approaches, such as transcriptomics or proteomics, to provide deep insights into molecular mechanisms and drug responses. This integration enhances the power of the STEMOD™ platform, offering a more comprehensive understanding of your drug discovery targets.
-
Q: What kind of data or readouts can we expect?
A: Our platform offers a wide range of readouts, including phenotypic changes, genetic and epigenetic alterations, and functional assays such as electrophysiological recordings, secretion assays, or metabolic activity measurements. We can also provide high-content imaging data, enabling detailed analysis of cell morphology, proliferation, and differentiation. Depending on your specific needs, we can tailor the data output to include toxicity profiling, efficacy studies, or disease modeling to provide comprehensive insights into your drug candidates.
Scientific Resources
For Research Use Only. Not For Clinical Use.
